Want to see ENDV full AI Analyst Report?
Endonovo Therapeutics (ENDV) Q2 2023 Earnings Report
ENDV Q2 2023 EPS Results
- Actual EPS
- $0.00
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$0.02
ENDV Q2 2023 Revenue Results
- Actual Revenue
- $45.20K
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +6853.85%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/21/2023
- Time
- TBA
- Conference Call
- Monday, August 21, 2023
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
ENDV Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 18, 2024 | 2024 (Q3) | ―-0.00 | 0 | 33.33% (+0.00) | |
| Aug 19, 2024 | 2024 (Q2) | ―-0.00 | 0 | -100.00% (-0.00) | |
| Jun 17, 2024 | 2024 (Q1) | ―-0.00 | 0 | -125.00% (-0.01) | |
| Nov 22, 2023 | 2023 (Q3) | ―- | 0 | ― | |
| Aug 21, 2023 | 2023 (Q2) | ―-0.00 | -0.02 | 94.74% (+0.02) | |
| Nov 21, 2022 | 2022 (Q3) | ―-0.00 | -0.02 | 82.61% (+0.02) | |
| Aug 22, 2022 | 2022 (Q2) | ―-0.02 | -0.02 | 13.64% (+0.00) | |
| May 19, 2022 | 2021 (Q4) | ―-0.03 | -0.06 | 53.13% (+0.03) | |
| May 19, 2022 | 2022 (Q1) | ―- | -0.06 | ― | |
| Nov 19, 2021 | 2021 (Q3) | ―-0.02 | -0.07 | 65.15% (+0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
